Irazole-DSR Capsule is a combination medication containing Domperidone 30mg and Pantoprazole 40mg, formulated to manage gastrointestinal disorders associated with acid reflux and motility disturbances. Pantoprazole, a proton pump inhibitor, effectively suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, thereby providing symptomatic relief from conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the tone of the lower esophageal sphincter and accelerating gastric emptying, which helps alleviate symptoms like nausea, vomiting, bloating, and early satiety. The synergistic action of these two agents addresses both acid-related mucosal damage and delayed gastric emptying, offering comprehensive relief in patients with dyspepsia and reflux symptoms. Irazole-DSR is typically prescribed for short-term use under medical supervision, with dosage adjustments based on clinical response and tolerability. Caution is advised in patients with cardiac conditions due to the potential risk of QT interval prolongation associated with Domperidone. This combination should be used with consideration of contraindications and drug interactions to ensure optimal therapeutic outcomes.